多焦点人工晶状体对比单焦点人工晶状体在白内障手术中的成本效果分析
该成本效果分析构建马尔可夫模型模拟接受多焦点或单焦点人工晶状体的白内障手术患者,术后可经历眼镜依赖、眩光和光晕。多焦点人工晶状体较单焦点增加0.71 QALY、增加成本3415美元,ICER为4805美元/QALY,在50000美元/QALY的支付意愿阈值下99.9%概率具有成本效果。
要点
- 多焦点较单焦点IOL增加0.71 QALY、增加成本3415美元,ICER为4805美元/QALY。
- 模型对患者年龄、两种IOL的眼镜依赖概率及戴镜负效用最敏感。
- 概率敏感性分析示在50000美元/QALY阈值下99.9%概率多焦点IOL具成本效果。
核心结论
- 从社会与医疗保健部门视角,对希望更高概率摆脱眼镜的患者,多焦点IOL较单焦点IOL具有成本效果。
- 作者指出仍需更多研究进一步评估多焦点IOL的疗效。
研究设计与样本
- 成本效果分析,构建马尔可夫模型模拟白内障手术中接受多焦点或单焦点IOL的患者。
- 术后状态包括眼镜依赖、眩光和光晕;以每获得一个QALY的增量成本(ICER)衡量成本效果。
主要发现
- 多焦点IOL较单焦点IOL增加0.71 QALY,增加成本3415美元。
- 从社会与医疗保健部门视角,ICER为4805美元/QALY。
- 模型对患者年龄、多焦点与单焦点IOL的眼镜依赖概率及戴镜负效用最敏感。
- 概率敏感性分析显示,在50000美元/QALY支付意愿阈值下,多焦点IOL有99.9%的概率为成本效果更优选项。
关键数值与推荐
- ICER低于50000美元/QALY的标准支付意愿阈值视为具有成本效果。
- 多焦点IOL的ICER为4805美元/QALY,低于该阈值。
临床怎么用
- 对希望提高脱镜概率的白内障患者,多焦点IOL在50000美元/QALY阈值下可视为具有成本效果的策略。
- 决策时需考虑患者年龄、眼镜依赖概率及戴镜负效用等敏感因素。
局限性
- 作者指出需更多研究进一步评估多焦点IOL的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the cost-effectiveness of multifocal intraocular lenses (IOLs) compared to that of monofocal IOLs from a societal and health care sector perspective. DESIGN: Cost-effectiveness analysis. METHODS: A Markov model was constructed that simulated patients who received either multifocal or monofocal IOLs during cataract surgery. Postoperatively, patients could experience spectacle dependence, glare, and haloes. Cost-effectiveness was determined by measuring the incremental cost-effectiveness ratio (ICER) as the incremental cost in dollars per quality-adjusted life year (QALY) gained. Treatments with an ICER below the standard willingness-to-pay (WTP) threshold of $50,000/QALY were considered cost effective. One-way sensitivity analyses and probabilistic sensitivity analyses were used to evaluate model sensitivity to cost, utilities, and other model inputs. RESULTS: Multifocal IOLs were associated with a 0.71 QALY increase at an increased cost of $3,415 compared with monofocal IOLs, leading to an ICER of $4,805/QALY from the societal and health care sector perspectives. The cost-effectiveness model was most sensitive to patient age, probability of spectacle dependence with multifocal IOLs and monofocal IOLs, and the disutility of glasses. Probabilistic sensitivity analysis found multifocal IOLs to be the cost-effective option compared with monofocal IOLs 99.9% of the time at a WTP threshold of $50,000/QALY. CONCLUSIONS: From a societal and health care perspective, multifocal IOLs would be considered a cost-effective strategy compared to monofocal IOLs for patients who desire a higher chance to be spectacle-free. However, more studies need to be conducted to further evaluate the efficacy of multifocal IOLs.
引用
- Hu JQ, Sarkar R, Sella R, et al. Cost-Effectiveness Analysis of Multifocal Intraocular Lenses Compared to Monofocal Intraocular Lenses in Cataract Surgery. Am J Ophthalmol. 2019. PMID: 30905724. doi:10.1016/j.ajo.2019.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。